CoChat

Evaluating the effect of immune cells on the outcome of patients with mesothelioma

Open access
Chee, Serena J, Lopez, Maria, Mellows, Toby, Gankande, Sharmali, Moutasim, Karwan A, Harris, Scott, Clarke, James, Vijayanand, Pandurangan, Thomas, Gareth J, Ottensmeier, Christian H · 2017 · British Journal of Cancer
Cited by 69

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

We systematically assessed the prognostic and predictive value of infiltrating adaptive and innate immune cells in a large cohort of patients with advanced mesothelioma. A tissue microarray from 302 samples was constructed. Markers of adaptive immune response in T-cells (CD8 + , FOXP3 + , CD4 + , CD45RO + , CD3 + ) and B-cells (CD20 + ), and of innate immune response; neutrophils (NP57 + ), natural killer cells (CD56 + ) and macrophages (CD68 + ) were evaluated. We found that in the epithelioid tumours, high CD4 + and CD20 + counts, and low FOXP3 + , CD68 + and NP57 + counts linked to better outcome. In the non-epithelioid group low CD8 + and low FOXP3 + counts were beneficial. On multivariate analysis low FOXP3 + remained independently associated with survival in both groups. In the epithelioid group additionally high CD4 + , high CD20 + , and low NP57 + counts were prognostic. Our data demonstrate for the first time, in predominately advanced disease, the association of key markers of adaptive and innate immunity with survival and the differential effect of histology. A better understanding of the immunological drivers of the different subtypes of mesothelioma will assist prognostication and disease-specific clinical decision-making.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.2017.269

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 69

Metadata

Authors
Chee, S. J., Lopez, M., Mellows, T., Gankande, S., Moutasim, K. A., Harris, S., Clarke, J., Vijayanand, P., Thomas, G. J., & Ottensmeier, C. H.
Venue
British Journal of Cancer
Published
2017-08-17
Volume
117
Issue
9
Pages
1341-1348
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2748527944
Cited by
69
References
19
FWCI
4.66
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating the effect of immune cells on the outcome of patients with mesothelioma. https://app.cochat.ai/papers/10.1038/bjc.2017.269
The paper
Chee, S. J., Lopez, M., Mellows, T., Gankande, S., Moutasim, K. A., Harris, S., Clarke, J., Vijayanand, P., Thomas, G. J., & Ottensmeier, C. H. (2017). Evaluating the effect of immune cells on the outcome of patients with mesothelioma. British Journal of Cancer. https://doi.org/10.1038/bjc.2017.269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.